For those currently using semaglutide or tirzepatide who want to transition to retatrutide, a washout period between discontinuing the current peptide and initiating retatrutide is advisable
And yet, the most recent National Health Interview Survey reports only 38 percent of those who attempted to quit smoking receive effective treatment, with 36.3 percent receiving medication, 7.3 percent receiving counseling, and 6.4 percent received optimal treatment with both counseling and medication
This can be concerning, but understanding the underlying causes and how to manage them can help patients continue their treatment safely
Across the SURMOUNT trials, hair loss affected 5.4 percent of tirzepatide users (119 of 2,183) against 0.9 percent on placebo (22 of 2,221)
INFORMATION What is Semaglutide (50 mg)